We Make Better Biologics is a multi-year, multi-platform brand campaign developed to unify and elevate LifeNet Health’s diverse business segments—including Spine & Orthopedics, Sports Medicine, CMF, Cardiovascular, and Dental. Designed with modularity and scalability in mind, the campaign supports over 30 registered trade names and contributes to a revenue stream exceeding $250 million annually.
The visual language was simple and was true to the nature of the products. “Editors marks” allowed us to illustrate quickly that LifeNet Health doesn’t make biologics— we make them better. This creative concept was then carried across various messaging and copy as well as used as a visual device to highlight and markup images.
Through strategic refinement of messaging, tone, and visual language, the core campaign narrative was adapted across market segments — from orthopedic surgeons and hospital procurement teams to emerging B2B partners.
Precision targeting enabled us to engage audiences at various stages of the customer journey — facilitating authentic, 1:1 connections.
The media mix was strategically balanced between paid placements and earned exposure, reinforcing campaign objectives while maximizing ROI across platforms.
Cutting Through
the Red Tape
In healthcare and medical device marketing, strict regulatory guidelines prohibit unsubstantiated claims—even seemingly simple language like “healing” can imply improved patient outcomes and must be clinically validated. The We Make Better Biologics campaign was crafted with these constraints in mind, delivering a bold, confident message that clearly communicates LifeNet Health’s value proposition—without overstepping compliance boundaries. The phrase positions the organization as a leader in the space—striking the balance between regulatory sensitivity and brand differentiation.
